Archives

What Makes an Effective Leader? In this week’s Q&A, we’re tackling things a bit differently. Natalie LaFranzo, Director of Scientific Projects and Market Development, and JT Forys, Director [...]

Major Improvements in Clinical Trials are Near Cofactor Genomics’ COO, Dave Messina, is featured in this week’s Q&A. Dave talks about the weaknesses in current clinical trial [...]

Running a Clinical Lab and Realizing the Potential to Make a Big Impact in Patients’ Lives In this week’s Q&A Cofactor Genomic’s Lab Director, JT Forys, shares his experiences [...]

Predictive Immune Modeling using RNA Provides New Context In this week’s Q&A Cofactor Genomic’s CEO, Jarret Glasscock, explains Predictive Immune Modeling, Health Expression Models, and [...]

Awards Scientists and Clinicians Who Create Predictive Immune Models and Multidimensional Biomarkers Using the Cofactor ImmunoPrismTM Assay NEW YORK (BusinessWire), February 6, 2019 [...]

SAN FRANCISCO, Feb. 4, 2019 (FIERCE PHARMA) – Advances in new immunotherapies and novel combinations of therapies have resulted in an explosion of oncology clinical trials. While many of [...]